Allopurinol
Product Images NDC 33261-597

4 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 33261-597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Allopurinol Structural Formula (Allopurinol 100 mg And 300 mg For Watson 1)

Allopurinol Structural Formula (Allopurinol 100 mg And 300 mg For Watson 1)
Chemical structure diagram of Allopurinol, showing its molecular framework with nitrogen and oxygen atoms connected in a specific arrangement.*
FDA Label Image

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol 100 mg And 300 mg For Watson 2)

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol 100 mg And 300 mg For Watson 2)
Chemical structures and conversion pathways of Allopurinol and related compounds Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid are depicted, showing molecular transformations between these purine derivatives.*
FDA Label Image

Image Label (Allopurinol 100 mg And 300 mg For Watson 3)

Image Label (Allopurinol 100 mg And 300 mg For Watson 3)
Packaging label for Allopurinol 100 mg tablets, supplied by Aidarex Pharmaceuticals LLC. The label indicates a package count of 30 tablets and states it is a generic for Zyloprim. The manufacturer is Watson Pharma Private Ltd., India. The label includes the NDC code 33261-0810-30 and prescribing information sections.*
FDA Label Image

Image Label (Allopurinol 100 mg And 300 mg For Watson 4)

Image Label (Allopurinol 100 mg And 300 mg For Watson 4)
Allopurinol 300 mg tablet label from Aidarex Pharmaceuticals LLC, indicating 30 tablets per package. The label displays the active ingredient Allopurinol 300 mg, generic for Zyloprim, with NDC 33261-0597-30. Manufacturer is Watson Pharma Private Ltd, India. Additional instructions and patient information areas are outlined on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.